Results 51 to 60 of about 4,412 (151)

COVID-19 BBIBP-CorV vaccine and transient heart block - A phenomenon by chance or a possible correlation - A case report [PDF]

, 2021
Importance: Bradyarrhythmia during COVID19 illness carries prognostic significance. Electrophysiological side effects of COVID19 vaccine remain largely unknown.
Ali, Jamshed, Khan, Aamir Hameed, Saadia, Sheema, Shams, Pirbhat, Sultan, Fateh Ali Tipoo, Tai, Javed   +5 more
core   +1 more source

Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients [PDF]

, 2022
Vaccination against SARS-CoV-2 to prevent COVID-19 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs).
Balog Attila, Balog József Ágoston, Gémes Nikolett, Honfi Dániel György, Nagy Lajos I., Neuperger Patrícia, Puskás László G., Szabó Enikő, Szebeni Gábor, Toldi Gergely   +9 more
core   +1 more source

Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population

Vaccines, 2022
Fifty five percent of the Pakistani population is still unvaccinated with the two-dose protocol of COVID-19 vaccines. This study was undertaken to determine the seroconversion rate and antibody titers following the two-dose BBIBP-CorV protocol, and to ...
Javeria Aijaz, Shakir Hussain, Fouzia Naseer, Fatima Kanani, Sabiha Anis, Samreen Sarfaraz, Saima Saeed, Hina Farooq, Saba Jamal   +8 more
doaj   +1 more source

Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis [PDF]

, 2023
BACKGROUND: Inactivated, whole-virion vaccines have been used extensively in the SARS-CoV-2 pandemic. Its efficacy and effectiveness across regions have not been systematically evaluated.
Chan, EWY, Ho, CMY, Ho, SSH, Kwan, CM, Lai, FTT, Law, M, Tsang, GKC, Wong, ICK, Yan, VKC, Yiu, HHE   +9 more
core  

Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population

Public Health in Practice, 2022
Objectives: In a context of COVID-19 vaccine shortages, this study sought to evaluate the safety and efficacy of receiving one dose of Gam-COVID-Vac rAd26 followed by a second COVID-19 vaccine dose of either Gam-COVID-Vac rAd5, ChAdOx1 nCoV-19 or BBIBP ...
M.A. Kundro, M.H. Losso, A. Macchia, I. Pastor, M. Alonso Serena, C. Gestoso, L. Moreno Macías, F. Crupi, M.C. Acosta, S. Ivalo, M. Ghioldi, M.B. Bouzas, L. Mammana, I. Zapiola, I. Mazzitelli, A. Varese, J. Geffner, C. Biscayart, P. Angeleri, E. Lopez, A. Gentile, D. Ferrante, F. Gonzalez B. de Quiros   +22 more
doaj   +1 more source

Emerging COVID-19 vaccines: safety, efficacy and universality [PDF]

, 2021
Le nouveau coronavirus, le coronavirus 2 du syndrome respiratoire aigu sévère (SRAS-CoV-2), a causé plus de 3 807 276 décès dans le monde et 9 213 décès au Maroc en juin 152021, en plus d'un énorme bouleversement économique et social à l'échelle ...
AIT SSI, Saadia, BADOU, Abdallah, EL AZHARI, Khadija, MIYARA, Kenza, SOUAT, Sanaa   +4 more
core   +2 more sources

Применение количественного иммуноферментного анализа для определения концентрации S-антигена в цельновирионных инактивированных адсорбированных коронавирусных вакцинах [PDF]

, 2022
The severe consequences and high mortality of COVID-19 prompted the development of a wide range of preventive vaccines. The first vaccines to be tested were developed in China and formulated as inactivated SARS-CoV-2 adsorbed on aluminium hydroxide.
A. G. Krasko, A. S. Oksanich, E. L. Gasich, G. M. Ignatyev, T. G. Samartseva, А. Г. Красько, А. С. Оксанич, Г. М. Игнатьев, Е. Л. Гасич, Т. Г. Самарцева   +9 more
core   +4 more sources

Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine

The Innovation, 2023
The BBIBP-CorV severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inactivated vaccine has been authorized for emergency use and widely distributed. We used single-cell transcriptome sequencing to characterize the dynamics of immune responses to
Jianhua Yin, Yingze Zhao, Fubaoqian Huang, Yunkai Yang, Yaling Huang, Zhenkun Zhuang, Yanxia Wang, Zhifeng Wang, Xiumei Lin, Yuhui Zheng, Wenwen Zhou, Shuo Wang, Ziqian Xu, Beiwei Ye, Yaxin Guo, Wenwen Lei, Lei Li, Jinmin Tian, Jinxian Gan, Hui Wang, Wei Wang, Peiyao Ma, Chang Liu, Xiaoyu Wei, Xuyang Shi, Zifei Wang, Yang Wang, Ying Liu, Mingming Yang, Yue Yuan, Yumo Song, Wen Ma, Zhuoli Huang, Ya Liu, Yunting Huang, Haorong Lu, Peipei Liu, Hao Liang, Yong Hou, Xun Xu, Longqi Liu, Yuntao Zhang, Guizhen Wu, George F. Gao, Xin Jin, Chuanyu Liu, Xiaoming Yang, William J. Liu   +47 more
doaj   +1 more source

SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines [PDF]

, 2022
Numerous safe and effective coronavirus disease 2019 vaccines have been developed worldwide that use various delivery technologies and engineering strategies.
Ahmed, Kumail, Bandera, Alessandra, Bowen, John E, Brown, Jack T, Chu, Helen Y, Corti, Davide, Crotty, Shane, Dan, Jennifer M, Franko, Nicholas M, Geffner, Jorge, Gori, Andrea, Grifantini, Renata, Huang, Yimin, Iqbal, Najeeha Talat, Jerak, Josipa, Joshi, Anshu, Logue, Jennifer K, Low, Jun Siong, Maynard, Jennifer A, Mazzitelli, Ignacio G, McCallum, Matthew, Nguyen, Annalee W, Park, Young-Jun, Posavad, Christine M, Sallusto, Federica, Sette, Alessandro, Shariq, Asefa, Sharkey, William K, Silva, Rui P, Simmerling, Carlos, Snell, Gyorgy, Sprouse, Kaitlin R, Stewart, Cameron, Tiles, Sasha W, Tortorici, M Alejandra, Van Voorhis, Wesley C, Veesler, David, Walls, Alexandra C, Weiskopf, Daniela, Zhang, Zeli   +39 more
core   +1 more source

A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?

Frontiers in Endocrinology, 2022
AimTo determine the efficacy and safety of inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer.MethodsIn this multi- institutional cohort study, a total of 160 breast cancer patients (mean age of 50.01 ± 11.5 years old) were ...
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, Babak PeyroShabany, Mohsen Tabasi, Danial Fazilat-Panah, Mahtab Khajeh, Arezoo Mehrabian, Mansoureh Dehghani, James S. Welsh, Batol Keykhosravi, Azam Akbari Yazdi, Mona Ariamanesh, Ahmad Ghasemi, Gordon Ferns, Seyed Alireza Javadinia   +15 more
doaj   +1 more source